Y Chen - Hematology Oncology Consultants

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 21 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Timeliness of Care Among Patients With Small Cell Lung Cancer Evaluated by a Multi-disciplinary Team

M. Block, L. LeQuia, A. Frisch, M. Ahmed, R. Sinniah,Y. Chen, G. Cumbo-Nacheli

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

引用0浏览0引用

Durvalumab (D) plus platinum-etoposide (EP) in first-line extensive-stage SCLC (ES SCLC): Effect of age and platinum agent on outcomes in CASPIAN

N. Reinmuth, J. W. Goldman,Y. Chen, K. Hotta, G. Statsenko, M. J. Hochmair,M. Ozguroglu, J. H. Ji, M. C. Garassino, A. Poltoratskiy, F. Verderame, L. Havel,

ANNALS OF ONCOLOGY（2022）

引用0浏览0引用

Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN

L. Paz-Ares,Y. Chen,N. Reinmuth,K. Hotta,D. Trukhin,G. Statsenko, M.J. Hochmair,M. Özgüroğlu,J.H. Ji,M.C. Garassino,O. Voitko,A. Poltoratskiy,

ESMO Open（2022）

引用74浏览0WOS引用

1530P Durvalumab (D) + platinum-etoposide (EP) in first-line extensive-stage SCLC (ES SCLC): Effect of age and platinum agent on outcomes in CASPIAN

N. Reinmuth, J.W. Goldman,Y. Chen, K. Hotta, G. Statsenko, M.J. Hochmair, M. Özgüroğlu, J.H. Ji, M.C. Garassino, A. Poltoratskiy, F. Verderame, L. Havel,

Annals of Oncology (2022): S1245-S1246

引用0浏览0引用

LBA6 Neoadjvuant versus adjuvant pembrolizumab for resected stage III-IV melanoma (SWOG S1801)